MoonLake Immunotherapeutics Overview
MoonLake Immunotherapeutics Target Price
Analysts' 12-month price predictions for MLTX.
Share Price
$39.74
Average Target Price
$67.00
68.6% upside
68.6% upside1 analysts in the last 4 months
High: $67 | Low: $67
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-03-18 | RBC Capital | $67 | 68.6% upside |  |
| 2024-07-01 | H.C. WainwrightRaghuram Selvaraju | $100 | 151.6% upside | |
| 2024-04-02 | Goldman SachsRichard Law | $62 | 56% upside | |
| 2023-08-31 | NeedhamSerge Belanger | $76 | 91.2% upside | |